Mechanism Involved in the Antiplatelet Activity of Naloxone in Human Platelets
Authors:
- Wei-Chun HungWHWei-Chun Hung
- Ling-Wen LeeLLLing-Wen Lee
- Pei-Te ChangPCPei-Te Chang
- Ya-Chen KanYKYa-Chen Kan
- Mao-Hsiung YenMYMao-Hsiung Yen
- 1 February 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 231 (1) , 12-16
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Triflavin, an Arg-Gly-Asp-Containing Peptide, Inhibits the Adhesion of Tumor Cells to Matrix Proteins via Binding to Multiple Integrin Receptors Expressed on Human Hepatoma CellsExperimental Biology and Medicine, 1996
- Triflavin, an RGD-containing antiplatelet peptide, binds to GPIIIa of ADP-stimulated plateletsBiochemical and Biophysical Research Communications, 1992
- A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venomBiochemical Journal, 1991
- High Dose Naloxone Produces Cerebral VasodilationNeurosurgery, 1984
- Cerebral and Systemic Vascular Effects of Naloxone in Pentobarbital-anesthetized Normal DogsNeurosurgery, 1984
- Effects of alcohols on ADP-induced aggregation and membrane fluidity of gel-filtered bovine blood plateletsThe Journal of Membrane Biology, 1984
- Beneficial effect of i.c.v. naloxone in anaphylactic shock is mediated through peripheral β-adrenoceptive mechanismsBrain Research, 1984
- The Effect of Naloxone and Cyproheptadine on Pulmonary Platelet Trapping, Hypotension, and Platelet Aggregability in Traumatized Dogs1983
- Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregationNature, 1975
- TREATMENT OF DRUG OVERDOSAGE WITH NALOXONE, A SPECIFIC NARCOTIC ANTAGONISTThe Lancet, 1973